Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (AMP)-activated protein kinase signaling pathway
Main Authors: | Xin-Xin Zhu, Zong-Hao Feng, Lin-Zhi Liu, Yan Zhang, Peng Lyu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2021-03-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000001363 |
Similar Items
-
Xylazine Activates Adenosine Monophosphate-Activated Protein Kinase Pathway in the Central Nervous System of Rats.
by: Xing-Xing Shi, et al.
Published: (2016-01-01) -
Role of the Peroxisome Proliferator-Activated Receptors, Adenosine Monophosphate-Activated Kinase, and Adiponectin in the Ovary
by: Joëlle Dupont, et al.
Published: (2008-01-01) -
Kinase-anchoring proteins and the intracellular targeting of cyclic adenosine monophosphate (cAMP)-dependent protein kinase
by: Davis, Alison Jane
Published: (2007) -
Carvone Decreases Melanin Content by Inhibiting Melanoma Cell Proliferation via the Cyclic Adenosine Monophosphate (cAMP) Pathway
by: Wesuk Kang, et al.
Published: (2020-11-01) -
Adenosine monophosphate–activated protein kinase in diabetic nephropathy
by: Yaeni Kim, et al.
Published: (2016-06-01)